Legend Biotech

Legend Biotech Debt

The Debt of Legend Biotech (LEGN) as of Nov 6, 2026 is 326.50 M USD. In the previous year, Debt was 350.60 M USD — a change of -6.87% (lower).

Debt

326.50 MUSD

YoY

-6.87%

Last updated:

In 2025, Legend Biotech's total debt was 326.50 M USD, a -6.87% change from the 350.60 M USD total debt recorded in the previous year.

The Legend Biotech Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
4.30 M USD
Jan 1, 2019
6.10 M USD
Jan 1, 2020
3.70 M USD
Jan 1, 2021
123.00 M USD
Jan 1, 2022
284.50 M USD
Jan 1, 2023
328.67 M USD
Jan 1, 2024
350.60 M USD
Jan 1, 2025
326.50 M USD
The Legend Biotech Debt history
YEARDebtYoY
326.50 MUSD-6.87%
350.60 MUSD+6.67%
328.67 MUSD+15.53%
284.50 MUSD+131.30%
123.00 MUSD+3,224.32%
3.70 MUSD-39.34%
6.10 MUSD+41.86%
4.30 MUSD+1,333.33%
300,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Legend Biotech Stock analysis

What does Legend Biotech do? Legend Biotech Corp is a leading biopharmaceutical company specializing in the discovery and development of innovative cell therapies for the treatment of serious diseases such as cancer. The company was founded in 2015 as a subsidiary of Genscript Biotech Corp and is headquartered in Somerset, New Jersey, USA. Additionally, the company also operates locations in China and Europe. Legend Biotech is one of the most popular companies on Eulerpool.

Debt Details

Understanding Legend Biotech's Debt Structure

Legend Biotech's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Legend Biotech's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Legend Biotech’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Legend Biotech’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Legend Biotech stock

Debt of Legend Biotech is 326.50 M USD in 2025.

Debt of Legend Biotech changed from 350.60 M USD to 326.50 M USD, representing a -6.87% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Legend Biotech since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Legend Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Legend Biotech

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Legend Biotech